Israel-based AI-powered clinical intelligence provider Navina has raised US$55 million in its series C funding round. The investment, led by Growth Equity at Goldman Sachs Alternatives, brings the company’s total funding to US$100 million.

Existing investors, including Vertex Ventures Israel, Grove Ventures, and ALIVE, also participated in this funding round.